Houston Man Indicted in Fayetteville for Selling Designer Drugs Around the World
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Houston Man Indicted in Fayetteville for Selling Designer Drugs Around the World

Houston Man Indicted in Fayetteville for Selling Designer Drugs Around the World

January 20, 2026
|
Share Article
|
Download Press Release
For Immediate Release
Contact: SA Sheri Kindred
Phone Number: 571-362-3458

RALEIGH, N.C. – A federal grand jury indicted Miqual Antwan Dysheen Spivey for the crimes of selling the designer drug MDMB-4en-PINACA, conspiring with others to possess and sell the drug, and money laundering.

According to the indictment, Spivey, 27, owned and operated Bummy Legion, a Texas company that sells liquids intended for use in electronic vaporizers (often called “vape juices”). The indictment alleges that Spivey sold Bummy Legion’s vape juices through the company’s website and shipped them from post offices in Fayetteville, North Carolina. Although Bummy Legion’s website marketed the vape juices as derived from “organic blue lotus and valerian root,” the indictment alleges that the true active ingredient was the synthetic cannabinoid MDMB-4en-PINACA. PINACA is a dangerous Schedule I controlled substance which, according to the DEA, “has been associated with numerous reports of emergency [room visits], severe intoxication, and death.”

The indictment also charges Spivey with ten separate violations of the money-laundering statutes, each representing a separate transaction of over $10,000 with the proceeds of his allegedly illicit sales. As alleged in the indictment, those transactions ranged in value from $11,324.75 to $233,779.84. Other information presented in court indicates that Spivey made nearly $5 million through online sales of Bummy Legion vape juices in the two years since PINACA was placed on Schedule I.

“This defendant took dangerous and unregulated vaping products and falsely marketed them as safe to use, putting children and unknowing vape users at risk of severe intoxication and death,” said Attorney General Pamela Bondi. “The distribution of illicit vaping products is a national security and public health issue that this Department of Justice will continue to prioritize, combat, and eradicate.”

“Families need to know that a vape product is not safe just because strangers sell it online or in a store front,” said U.S. Attorney Ellis Boyle. “These products can effectively rot your lungs from the inside out. Unregulated manufacturers can sell dangerous vape products with zero quality control or regulation. Our office will continue to focus on preventing children from using dangerous products.”

According to information presented at Spivey’s detention hearing, law enforcement executed five search warrants on January 13, 2026, three in Houston, Texas, and two in in Fayetteville, North Carolina.  These search warrants resulted in the seizure of four guns, 715 gallons of suspected liquid PINACA, and approximately $40,000 US currency.

“Illegal vape products frequently target young and vulnerable consumers through online sales and misleading marketing,” said Jae W. Chung, Special Agent in Charge of the DEA Atlanta Division. “As part of DEA Fentanyl Free America Initiative, this indictment reflects our commitment to protecting our communities and preventing unlawful products from reaching our communities.”

The federal grand jury charged Spivey with conspiracy to sell and possess with intent to distribute a Schedule I controlled substance, seven counts of selling a Schedule I controlled substance, and ten counts of engaging in monetary transactions of a value over $10,000 with the proceeds of a specified unlawful activity. If convicted, he faces a maximum penalty of 20 years in prison for each drug offense and a maximum penalty of 10 years in prison for each money-laundering offense.

W. Ellis Boyle, U.S. Attorney for the Eastern District of North Carolina, made the announcement. The DEA, U.S. Postal Inspection Service, Homeland Security Investigations, Department of the Army, Criminal Investigation Division, Fayetteville Police Department, and Cumberland County Sheriff’s Office are investigating the case. Executive Assistant U.S. Attorney Tyler Lemons supervised the investigation, and Assistant U.S. Attorney Chris Cogburn is prosecuting the case.

This is an ongoing investigation.  If you have information regarding purchases from Bummy Legion, possible adverse side effects, or other useful information, please contact the DEA at https://www.dea.gov/submit-tip or Army CID at www.cid.army.mil/tips.

  • Seized drugs and US currency
    Download Original Image
Download Press Release
###
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

Jae W. Chung Special Agent in Charge - Atlanta
@DEAAtlantaDiv
  • Facebook
  • X
  • linkedin
  • Email
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster